Media-OutReach Newswire AIM Vaccine’s 13-valent pneumonia conjugate vaccine obtained Production license
Media-OutReach Newswire IGC Continues to Promote Artificial Intelligence Strategic Transformation by "Technology Driven + Innovative Cooperation Model"
Media-OutReach Newswire AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval